Safety Updates and Recommendations for Healthcare Professionals on Anti-Tuberculosis Medication (1 of 2022/2023)
- Version
- Download 949
- File Size 286.20 KB
- File Count 1
- Create Date March 20, 2023
- Last Updated March 20, 2023
Safety Updates and Recommendations for Healthcare Professionals on Anti-Tuberculosis Medication (1 of 2022/2023)
Through one of its committees, the Pharmacovigilance Experts Review and Advisory Committee (PERAC), the Pharmacovigilance division conducted a causality assessment of the serious cases suspected to have been caused by some anti-tuberculosis medicines received at the Board and wishes to make recommendations for healthcare professionals on Anti-Tuberculosis Medication.
Attached Files
File | Action |
---|---|
SAFETY_UPDATE_1_0f_2022-2023.pdf | Download |